HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gert Jan Lammers Selected Research

Sodium Oxybate (gamma Hydroxybutyrate)

1/2014Glucose and fat metabolism in narcolepsy and the effect of sodium oxybate: a hyperinsulinemic-euglycemic clamp study.
1/2013Plasma total ghrelin and leptin levels in human narcolepsy and matched healthy controls: basal concentrations and response to sodium oxybate.
4/2012Altered circadian rhythm of melatonin concentrations in hypocretin-deficient men.
6/2011Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls.
3/2011Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls.
1/2010Sodium oxybate is an effective and safe treatment for narcolepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Gert Jan Lammers Research Topics

Disease

31Narcolepsy
04/2015 - 10/2002
15Cataplexy
04/2015 - 10/2002
5Obesity
01/2014 - 09/2003
4Sleep Disorders
12/2012 - 10/2002
3Parkinson Disease (Parkinson's Disease)
01/2008 - 10/2002
3Prader-Willi Syndrome (Syndrome, Prader-Willi)
07/2006 - 10/2002
2Body Weight (Weight, Body)
01/2013 - 03/2003
2Alzheimer Disease (Alzheimer's Disease)
12/2012 - 08/2012
2Nervous System Diseases (Neurological Disorders)
02/2009 - 10/2002
1Weight Loss (Weight Reduction)
01/2014
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
11/2013
1Abdominal Pain (Pain, Abdominal)
11/2013
1Idiopathic Hypersomnolence
08/2012
1Dementia (Dementias)
08/2012
1Substance-Related Disorders (Drug Abuse)
06/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2009
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2009
1Coffin-Lowry Syndrome (Syndrome, Coffin-Lowry)
07/2006
1Abdominal Obesity
09/2003
1Carcinoma (Carcinomatosis)
12/2002
1Adenocarcinoma
12/2002
1Sleep Initiation and Maintenance Disorders (Insomnia)
10/2002
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
10/2002
1Obstructive Sleep Apnea
10/2002
1Restless Legs Syndrome (Restless Legs)
10/2002
1Disorders of Excessive Somnolence (Hypersomnia)
10/2002

Drug/Important Bio-Agent (IBA)

29orexins (orexin)IBA
04/2015 - 10/2002
6Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
01/2014 - 01/2010
2Glucose (Dextrose)FDA LinkGeneric
01/2014 - 10/2013
2Growth Hormone (Somatotropin)IBA
06/2011 - 03/2003
2AntibodiesIBA
04/2003 - 12/2002
1Biological Markers (Surrogate Marker)IBA
06/2014
1Insulin (Novolin)FDA Link
01/2014
1Glycerol (Glycerine)FDA LinkGeneric
01/2014
1Amphetamine (Amfetamine)FDA LinkGeneric
11/2013
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
11/2013
1modafinil (armodafinil)FDA Link
11/2013
11- (3- (3- (4- chlorophenyl)propoxy)propyl)piperidineIBA
11/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2013
1LeptinIBA
01/2013
1HormonesIBA
01/2013
1OX40 LigandIBA
01/2013
1GhrelinIBA
01/2013
1Cathepsin HIBA
01/2013
1tranilast (N 5')IBA
08/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2012
1MelatoninIBA
04/2012
1N 30IBA
06/2011
1ProlactinIBA
03/2011
1Adrenocorticotropic Hormone (ACTH)FDA Link
03/2011
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2007
1Norrie diseaseIBA
07/2006
1AutoantibodiesIBA
05/2006
1GangliosidesIBA
04/2003
1AntigensIBA
04/2003
1Opsoclonus myoclonusIBA
12/2002
1human HLA-DQB1 proteinIBA
10/2002
1HLA-DQ Antigens (HLA-DQ)IBA
10/2002
1Psychotropic Drugs (Psychoactive Drugs)IBA
10/2002

Therapy/Procedure

1Aftercare (After-Treatment)
01/2014
1Cesarean Section (Caesarean Section)
10/2013
1Institutionalization (Institutionalized Persons)
08/2012